| 0 (0%) | 11-30 07:33 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 27.51 | 1-year : | 32.14 |
| Resists | First : | 23.55 | Second : | 27.51 |
| Pivot price | 21.46 |
|||
| Supports | First : | 20.44 |
Second : | 18.52 |
| MAs | MA(5) : | 22.35 |
MA(20) : | 20.81 |
| MA(100) : | 15.49 |
MA(250) : | 11.5 |
|
| MACD | MACD : | 1.3 |
Signal : | 1.4 |
| %K %D | K(14,3) : | 66.8 |
D(3) : | 77 |
| RSI | RSI(14): 61 |
|||
| 52-week | High : | 23.55 | Low : | 6.38 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ AVDL ] has closed below upper band by 49.6%. Bollinger Bands are 123.7% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 9 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 23.05 - 23.17 | 23.17 - 23.26 |
| Low: | 20.88 - 21.03 | 21.03 - 21.15 |
| Close: | 21.2 - 21.42 | 21.42 - 21.6 |
Sun, 30 Nov 2025
A Look at Avadel Pharmaceuticals (AVDL) Valuation Following Strong 2024 Performance - simplywall.st
Fri, 28 Nov 2025
Assessing Avadel Pharmaceuticals After Regulatory Milestones and 94.5% Share Price Surge in 2025 - simplywall.st
Thu, 27 Nov 2025
Avadel (AVDL) Drops 6.7% on Lack of Leads - Yahoo Finance
Wed, 26 Nov 2025
Behavioral Patterns of AVDL and Institutional Flows - news.stocktradersdaily.com
Wed, 19 Nov 2025
Halper Sadeh LLC Encourages SEMR, AVDL, CADE, DENN Shareholders to Contact the Firm to Discuss Their Rights - PR Newswire
Mon, 17 Nov 2025
Needham Reiterates a Hold Rating on Avadel Pharmaceuticals (AVDL) - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 98 (M) |
| Shares Float | 81 (M) |
| Held by Insiders | 4.7 (%) |
| Held by Institutions | 88.7 (%) |
| Shares Short | 7,690 (K) |
| Shares Short P.Month | 9,930 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 1 |
| Profit Margin | -0.2 % |
| Operating Margin | 2.5 % |
| Return on Assets (ttm) | -0.4 % |
| Return on Equity (ttm) | -0.4 % |
| Qtrly Rev. Growth | 54.9 % |
| Gross Profit (p.s.) | 2.41 |
| Sales Per Share | 2.54 |
| EBITDA (p.s.) | 0.02 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 35 (M) |
| Levered Free Cash Flow | 3 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 21.27 |
| Price to Sales | 8.44 |
| Price to Cash Flow | 60.76 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|